Mibefradil

Mibefradil
Systematic (IUPAC) name
(1S,2S)-2-(2-((3-(1H-benzo[d]imidazol-2-yl)propyl) (methyl)amino)ethyl)-6-fluoro-1-isopropyl- 1,2,3,4-tetrahydronaphthalen-2-yl 2-methoxyacetate
Clinical data
AHFS/Drugs.com Micromedex Detailed Consumer Information
MedlinePlus a607007
Pregnancy cat.  ?
Legal status Withdrawn from market
Routes Oral
Identifiers
CAS number 116644-53-2 Y
ATC code C08CX01
PubChem CID 60662
DrugBank DB01388
UNII 27B90X776A N
KEGG D08217 Y
ChEMBL CHEMBL45816 N
Chemical data
Formula C29H38FN3O3 
Mol. mass 495.63 g/mol
 N(what is this?)  (verify)

Mibefradil (Posicor) is a drug for the treatment of hypertension and chronic angina pectoris. It belongs to a group known as calcium channel blockers.

It is nonselective.[1]

On June 8, 1998, Roche announced the voluntary withdrawal of the drug from the market,[2] due to the potential for drug interactions, some of them serious, which may occur when it is taken together with some other medications.

References